North America Dialysis Market by Dialysis Type (Hemodialysis and Peritoneal Dialysis), Products & Services (Equipment, Consumables, Drugs, and Services), End User (In-center Dialysis, and Home Dialysis) – Global Opportunity Analysis and Industry Forecast, 2024–2030

North America Dialysis Market

Industry:  Life Sciences & Healthcare | Publish Date: Feb 2024 | No of Pages:  117 | No. Tables:  81 | No. Figures:  46

Market Overview:

The North America Dialysis Market size was valued at USD 64.38 billion in 2023, and is expected to reach USD 81.02 billion by 2030, with a CAGR of 3.3% from 2024 to 2030.

Dialysis is a life-sustaining medical procedure employed to manage patients with end-stage renal disease (ESRD) or acute kidney injuries. This market encompasses a spectrum of products and services, including hemodialysis and peritoneal dialysis equipment, dialysis consumables, and associated pharmaceuticals.

With the rising prevalence of kidney-related disorders and the increasing aging population, the market plays a critical role in delivering essential renal care, aiming to enhance patients' quality of life and improve overall healthcare outcomes.

The Surging Old-Age Population is Fueling the Market Towards Growth.

The growth of the dialysis market is significantly propelled by the aging population, which presents a multifaceted impact on the prevalence and management of kidney-related disorders. According to the latest report published by the World Health Organization in 2022, the number of people above 60 reached 1.4 billion in 2020, which is anticipated to reach 2.1 billion by 2050.

As individuals age, the heightened risk of chronic conditions such as diabetes and hypertension contribute to an increased incidence of Chronic Kidney Disease (CKD). The natural decline in kidney function associated with aging necessitates therapeutic interventions, with dialysis emerging as a critical lifeline for those experiencing significant renal decline.

The prevalence of comorbidities in older individuals further accentuates the demand for renal replacement therapies, positioning dialysis as a vital treatment method. The growing number of elderly individuals reaching the advanced stage of End-Stage Renal Disease thereby shaping the expanding landscape of the dialysis market.

 

Technological Developments in Dialysis Machines is Driving the Market to Grow:

Continuous innovation in dialysis machine technology is a significant driver for the dialysis market. Modern dialysis machines are equipped with advanced features, including improved filtration mechanisms, enhanced portability, and user-friendly interfaces. These technological advancements not only enhance the overall efficiency of dialysis treatments but also contribute to a more comfortable and convenient experience for both healthcare providers and patients.

As these machines evolve, they offer better precision in removing toxins from the blood, leading to improved outcomes and patient satisfaction. The integration of smart technologies and connectivity features further facilitates remote monitoring and data management, streamlining the overall dialysis process and supporting personalized treatment plans. The continuous pursuit of technological excellence in dialysis machines positions them as essential tools in the management of kidney-related disorders, driving the growth of the North America dialysis market.

Risk Attached to Infection and Complication Hinders the Market Expansion.

One of the significant challenges in the North America dialysis market is the inherent risk of infections and complications associated with these procedures. Gap in adherence to stringent hygiene practices and inadequate sterilization measures can elevate the effect of infections, posing a threat to patient health. Additionally, complications arising from the dialysis process itself can contribute to treatment challenges.

Introduction of At-Home Dialysis Solutions is creating Growth Opportunity for the Market:

The opportunity lies in offering dialysis solutions that patients can conveniently use at home. This approach enhances patient comfort, reduces the need for frequent hospital visits, and provides a flexible kidney care option.

As more individuals prefer the convenience of managing their dialysis in the comfort of their homes, companies that provide user-friendly and portable dialysis equipment stand to capture a significant market share.

By addressing the growing demand for home-based healthcare solutions, the dialysis market can attract a broader customer base and foster long-term patient satisfaction, contributing to overall market growth.

The U.S.  Holds the Dominant Market Share in the North America Dialysis Market

The technological advancements in healthcare are driving the growth in the market by extending life expectancy and enabling a larger demographic to live longer with chronic conditions. The advent of user-friendly home haemodialysis machines with intuitive interfaces and remote monitoring capabilities has revolutionized patient care. Patients can comfortably perform haemodialysis at home, reducing the need for frequent hospital visits.

Moreover, the surge in the market is prominently influenced by the aging demographic, marking a substantial impact on the prevalence and management of kidney-related disorders. As individuals age, the heightened risk of chronic conditions such as diabetes and hypertension become more pronounced, leading to an increased incidence of Chronic Kidney Disease (CKD). This demographic shift underscores the escalating demand for dialysis services as a crucial component in the management of kidney health in the aging population.

 

Mexico Marks the Fastest Growing Country in the Market

The technological advancements in healthcare are driving substantial growth in the dialysis market by extending life expectancy and enabling a larger demographic to live longer with chronic conditions. The advent of user-friendly home haemodialysis machines with intuitive interfaces and remote monitoring capabilities has revolutionized patient care. Patients can comfortably perform haemodialysis at home, reducing the need for frequent hospital visits.

Also, The surge in diabetes and hypertension cases in the country contributes significantly to the growth of the market. These chronic conditions, especially when unmanaged, can lead to kidney damage and eventually chronic kidney disease (CKD). With the increasing prevalence of diabetes and hypertension, there is a corresponding rise in the incidence of CKD, necessitating the use of dialysis as a crucial therapeutic intervention. The expanding patient pool with these comorbidities underscores the importance of dialysis services in managing kidney-related complications, driving the demand for dialysis treatments.

 

Competitive Landscape

Several market players operating in the North America dialysis market include Baxter International, Inc., DaVita Inc., Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, Medicators, Inc, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH, and others.

Key Market Segments

By Dialysis Type

  • Hemo Dialysis

  • Peritoneal Dialysis

By Products & Services

  • Equipment

  • Consumables

  • Drugs

  • Services

By End User

  • In-center Dialysis

  • Home Dialysis

By Region        

  • North America    

    • The U.S.

    • Canada

    • Mexico

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Market Size in 2023

USD 64.38 Billion

Revenue Forecast in 2030

USD 81.02 Billion

Growth Rate

CAGR of 3.3% from 2024 to 2030

Analysis Period

2023–2030

Base Year Considered

2023

Forecast Period

2024–2030

Market Size Estimation

Billion (USD)

Growth Factors

  • Technological Advancements in Dialysis Machines

  • The Surging Old-Age Population

Countries Covered

3

Companies Profiled

10

Market Share

Available for 10 companies

Customization Scope

Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs.

Test

1      INTRODUCTION

           1.1      REPORT DESCRIPTION

           1.2      RESEARCH METHODOLOGY

                         1.2.1      SECONDARY RESEARCH

                         1.2.2      DATA ANALYSIS FRAMEWORK

                         1.2.3      MARKET SIZE ESTIMATION

                         1.2.4      FORECASTING

                         1.2.5      PRIMARY RESEARCH AND DATA VALIDATION

2      NORTH AMERICA DIALYSIS MARKET – EXECUTIVE SUMMARY

           2.1.      MARKET SNAPSHOT, 2023 - 2030, MILLION USD

3      PORTER’S FIVE FORCE MODEL ANALYSIS

           3.1      BARGAINING POWER OF SUPPLIERS

           3.2      BARGAINING POWER OF BUYERS

           3.3      DEGREE OF COMPETITION

           3.4      THREAT OF SUBSTITUTE

           3.5      THREAT OF NEW ENTRANTS

4      MARKET SHARE ANALYSIS

           4.1      MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023

5      MARKET DYNAMICS

           5.1      GROWTH DRIVERS

                         5.1.1      DRIVER 1

                         5.1.2      DRIVER 2

                         5.1.3      DRIVER 3

                         5.1.4      DRIVER 4

           5.2      CHALLENGES

                         5.2.1      CHALLENGE 1

                         5.2.2      CHALLENGE 2

                         5.2.3      CHALLENGE 3

                         5.2.4      CHALLENGE 4

           5.3      OPPORTUNITIES

                         5.3.1      OPPORTUNITY 1

                         5.3.2      OPPORTUNITY 2

6      NORTH AMERICA DIALYSIS MARKET BY DIALYSIS TYPE

           6.1      OVERVIEW

           6.2      HEMO DIALYSIS

                         6.2.1      HEMO DIALYSIS MARKET, BY COUNTRY

           6.3      PERITONEAL DIALYSIS

                         6.3.1      PERITONEAL DIALYSIS MARKET, BY COUNTRY

7      NORTH AMERICA DIALYSIS MARKET BY PRODUCTS AND SERVICES

           7.1      OVERVIEW

           7.2      EQUIPMENT

                         7.2.1      EQUIPMENT MARKET, BY COUNTRY

           7.3      CONSUMABLES

                         7.3.1      CONSUMABLES MARKET, BY COUNTRY

           7.4      DRUGS

                         7.4.1      DRUGS MARKET, BY COUNTRY

           7.5      SERVICES

                         7.5.1      SERVICES MARKET, BY COUNTRY

8      NORTH AMERICA DIALYSIS MARKET BY END USER

           8.1      OVERVIEW

           8.2      IN-CENTER DIALYSIS

                         8.2.1      IN-CENTER DIALYSIS MARKET, BY COUNTRY

           8.3      HOME DIALYSIS

                         8.3.1      HOME DIALYSIS MARKET, BY COUNTRY

9     NORTH AMERICA DIALYSIS MARKET, BY COUNTRY

           9.1     OVERVIEW

           9.2     UNITED STATES

                         9.2.1     NORTH AMERICA DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.2.2     NORTH AMERICA DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.2.3     NORTH AMERICA DIALYSIS MARKET, BY END USER

           9.3     CANADA

                         9.3.1     NORTH AMERICA DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.3.2     NORTH AMERICA DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.3.3     NORTH AMERICA DIALYSIS MARKET, BY END USER

           9.4     MEXICO

                         9.4.1     NORTH AMERICA DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.4.2     NORTH AMERICA DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.4.3     NORTH AMERICA DIALYSIS MARKET, BY END USER

10   COMPANY PROFILES

           10.1   BAXTER INTERNATIONAL INC.

                         10.1.1   COMPANY OVERVIEW

                         10.1.2   COMPANY SNAPSHOT

                         10.1.3   OPERATING BUSINESS SEGMENTS

                         10.1.4   PRODUCT PORTFOLIO

                         10.1.5   BUSINESS PERFORMANCE

                         10.1.6   BUSINESS SEGMENTS

                         10.1.7   GEOGRAPHIC SEGMENTS

                         10.1.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.1.9   PRIMARY MARKET COMPETITORS

           10.2   DAVITA INC.

                         10.2.1   COMPANY OVERVIEW

                         10.2.2   COMPANY SNAPSHOT

                         10.2.3   OPERATING BUSINESS SEGMENTS

                         10.2.4   PRODUCT PORTFOLIO

                         10.2.5   BUSINESS PERFORMANCE

                         10.2.6   BUSINESS SEGMENTS

                         10.2.7   GEOGRAPHIC SEGMENTS

                         10.2.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.2.9   PRIMARY MARKET COMPETITORS

           10.3   NIKKISO CO. LTD.

                         10.3.1   COMPANY OVERVIEW

                         10.3.2   COMPANY SNAPSHOT

                         10.3.3   OPERATING BUSINESS SEGMENTS

                         10.3.4   PRODUCT PORTFOLIO

                         10.3.5   BUSINESS PERFORMANCE

                         10.3.6   BUSINESS SEGMENTS

                         10.3.7   GEOGRAPHIC SEGMENTS

                         10.3.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.3.9   PRIMARY MARKET COMPETITORS

           10.4   NXSTAGE MEDICAL, INC.

                         10.4.1   COMPANY OVERVIEW

                         10.4.2   COMPANY SNAPSHOT

                         10.4.3   OPERATING BUSINESS SEGMENTS

                         10.4.4   PRODUCT PORTFOLIO

                         10.4.5   BUSINESS PERFORMANCE

                         10.4.6   BUSINESS SEGMENTS

                         10.4.7   GEOGRAPHIC SEGMENTS

                         10.4.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.4.9   PRIMARY MARKET COMPETITORS

           10.5   ASAHI KASEI CORPORATION

                         10.5.1   COMPANY OVERVIEW

                         10.5.2   COMPANY SNAPSHOT

                         10.5.3   OPERATING BUSINESS SEGMENTS

                         10.5.4   PRODUCT PORTFOLIO

                         10.5.5   BUSINESS PERFORMANCE

                         10.5.6   BUSINESS SEGMENTS

                         10.5.7   GEOGRAPHIC SEGMENTS

                         10.5.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.5.9   PRIMARY MARKET COMPETITORS

           10.6   MEDICATORS, INC.

                         10.6.1   COMPANY OVERVIEW

                         10.6.2   COMPANY SNAPSHOT

                         10.6.3   OPERATING BUSINESS SEGMENTS

                         10.6.4   PRODUCT PORTFOLIO

                         10.6.5   BUSINESS PERFORMANCE

                         10.6.6   BUSINESS SEGMENTS

                         10.6.7   GEOGRAPHIC SEGMENTS

                         10.6.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.6.9   PRIMARY MARKET COMPETITORS

           10.7   FRESENIUS MEDICAL CARE AG AND CO. KGAA

                         10.7.1   COMPANY OVERVIEW

                         10.7.2   COMPANY SNAPSHOT

                         10.7.3   OPERATING BUSINESS SEGMENTS

                         10.7.4   PRODUCT PORTFOLIO

                         10.7.5   BUSINESS PERFORMANCE

                         10.7.6   BUSINESS SEGMENTS

                         10.7.7   GEOGRAPHIC SEGMENTS

                         10.7.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.7.9   PRIMARY MARKET COMPETITORS

           10.8   NIPRO CORPORATION

                         10.8.1   COMPANY OVERVIEW

                         10.8.2   COMPANY SNAPSHOT

                         10.8.3   OPERATING BUSINESS SEGMENTS

                         10.8.4   PRODUCT PORTFOLIO

                         10.8.5   BUSINESS PERFORMANCE

                         10.8.6   BUSINESS SEGMENTS

                         10.8.7   GEOGRAPHIC SEGMENTS

                         10.8.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.8.9   PRIMARY MARKET COMPETITORS

           10.9   B. BRAUN AVITUM AG

                         10.9.1   COMPANY OVERVIEW

                         10.9.2   COMPANY SNAPSHOT

                         10.9.3   OPERATING BUSINESS SEGMENTS

                         10.9.4   PRODUCT PORTFOLIO

                         10.9.5   BUSINESS PERFORMANCE

                         10.9.6   BUSINESS SEGMENTS

                         10.9.7   GEOGRAPHIC SEGMENTS

                         10.9.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.9.9   PRIMARY MARKET COMPETITORS

           10.10   DIAVERUM DEUTSCHLAND GMBH

                         10.10.1   COMPANY OVERVIEW

                         10.10.2   COMPANY SNAPSHOT

                         10.10.3   OPERATING BUSINESS SEGMENTS

                         10.10.4   PRODUCT PORTFOLIO

                         10.10.5   BUSINESS PERFORMANCE

                         10.10.6   BUSINESS SEGMENTS

                         10.10.7   GEOGRAPHIC SEGMENTS

                         10.10.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.10.9   PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. NORTH AMERICA DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 2. HEMO DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 3. PERITONEAL DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 4. NORTH AMERICA DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 5. EQUIPMENT, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 6. CONSUMABLES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 7. DRUGS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 8. SERVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 9. NORTH AMERICA DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 10. IN-CENTER DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 11. HOME DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 12. NORTH AMERICA DIALYSIS MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 13. UNITED STATES NORTH AMERICA DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 14. UNITED STATES NORTH AMERICA DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 15. UNITED STATES NORTH AMERICA DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 16. CANADA NORTH AMERICA DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 17. CANADA NORTH AMERICA DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 18. CANADA NORTH AMERICA DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 19. MEXICO NORTH AMERICA DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 20. MEXICO NORTH AMERICA DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 21. MEXICO NORTH AMERICA DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 22. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT

TABLE 23. BAXTER INTERNATIONAL INC.: OPERATING BUSINESS SEGMENTS

TABLE 24. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO

TABLE 25. BAXTER INTERNATIONAL INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 26. BAXTER INTERNATIONAL INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 27. BAXTER INTERNATIONAL INC.: KEY STRATERGY

TABLE 28. DAVITA INC.: COMPANY SNAPSHOT

TABLE 29. DAVITA INC.: OPERATING BUSINESS SEGMENTS

TABLE 30. DAVITA INC.: PRODUCT PORTFOLIO

TABLE 31. DAVITA INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 32. DAVITA INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 33. DAVITA INC.: KEY STRATERGY

TABLE 34. NIKKISO CO. LTD.: COMPANY SNAPSHOT

TABLE 35. NIKKISO CO. LTD.: OPERATING BUSINESS SEGMENTS

TABLE 36. NIKKISO CO. LTD.: PRODUCT PORTFOLIO

TABLE 37. NIKKISO CO. LTD.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 38. NIKKISO CO. LTD.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 39. NIKKISO CO. LTD.: KEY STRATERGY

TABLE 40. NXSTAGE MEDICAL, INC.: COMPANY SNAPSHOT

TABLE 41. NXSTAGE MEDICAL, INC.: OPERATING BUSINESS SEGMENTS

TABLE 42. NXSTAGE MEDICAL, INC.: PRODUCT PORTFOLIO

TABLE 43. NXSTAGE MEDICAL, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 44. NXSTAGE MEDICAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 45. NXSTAGE MEDICAL, INC.: KEY STRATERGY

TABLE 46. ASAHI KASEI CORPORATION: COMPANY SNAPSHOT

TABLE 47. ASAHI KASEI CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 48. ASAHI KASEI CORPORATION: PRODUCT PORTFOLIO

TABLE 49. ASAHI KASEI CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 50. ASAHI KASEI CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 51. ASAHI KASEI CORPORATION: KEY STRATERGY

TABLE 52. MEDICATORS, INC.: COMPANY SNAPSHOT

TABLE 53. MEDICATORS, INC.: OPERATING BUSINESS SEGMENTS

TABLE 54. MEDICATORS, INC.: PRODUCT PORTFOLIO

TABLE 55. MEDICATORS, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 56. MEDICATORS, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 57. MEDICATORS, INC.: KEY STRATERGY

TABLE 58. FRESENIUS MEDICAL CARE AG AND CO. KGAA: COMPANY SNAPSHOT

TABLE 59. FRESENIUS MEDICAL CARE AG AND CO. KGAA: OPERATING BUSINESS SEGMENTS

TABLE 60. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRODUCT PORTFOLIO

TABLE 61. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 62. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 63. FRESENIUS MEDICAL CARE AG AND CO. KGAA: KEY STRATERGY

TABLE 64. NIPRO CORPORATION: COMPANY SNAPSHOT

TABLE 65. NIPRO CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 66. NIPRO CORPORATION: PRODUCT PORTFOLIO

TABLE 67. NIPRO CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 68. NIPRO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 69. NIPRO CORPORATION: KEY STRATERGY

TABLE 70. B. BRAUN AVITUM AG: COMPANY SNAPSHOT

TABLE 71. B. BRAUN AVITUM AG: OPERATING BUSINESS SEGMENTS

TABLE 72. B. BRAUN AVITUM AG: PRODUCT PORTFOLIO

TABLE 73. B. BRAUN AVITUM AG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 74. B. BRAUN AVITUM AG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 75. B. BRAUN AVITUM AG: KEY STRATERGY

TABLE 76. DIAVERUM DEUTSCHLAND GMBH: COMPANY SNAPSHOT

TABLE 77. DIAVERUM DEUTSCHLAND GMBH: OPERATING BUSINESS SEGMENTS

TABLE 78. DIAVERUM DEUTSCHLAND GMBH: PRODUCT PORTFOLIO

TABLE 79. DIAVERUM DEUTSCHLAND GMBH: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 80. DIAVERUM DEUTSCHLAND GMBH: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 81. DIAVERUM DEUTSCHLAND GMBH: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. BARGAINING POWER OF SUPPLIERS

FIGURE 2. BARGAINING POWER OF BUYERS

FIGURE 3. DEGREE OF COMPETITION

FIGURE 4. THREAT OF SUBSTITUTE

FIGURE 5. THREAT OF NEW ENTRANTS

FIGURE 6. NORTH AMERICA DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

FIGURE 7. HEMO DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 8. PERITONEAL DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 9. NORTH AMERICA DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

FIGURE 10. EQUIPMENT, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 11. CONSUMABLES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 12. DRUGS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 13. SERVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 14. NORTH AMERICA DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

FIGURE 15. IN-CENTER DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 16. HOME DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 17. NORTH AMERICA DIALYSIS MARKET VALUE, BY REGION 2023-2030, (MILLION USD)

FIGURE 18. UNITED STATES NORTH AMERICA DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 19. UNITED STATES NORTH AMERICA DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 20. UNITED STATES NORTH AMERICA DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 21. CANADA NORTH AMERICA DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 22. CANADA NORTH AMERICA DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 23. CANADA NORTH AMERICA DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 24. MEXICO NORTH AMERICA DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 25. MEXICO NORTH AMERICA DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 26. MEXICO NORTH AMERICA DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 27. BAXTER INTERNATIONAL INC.: NET SALES, (2021-2023)

FIGURE 28. BAXTER INTERNATIONAL INC.: PRIMARY MARKET COMPETITORS

FIGURE 29. DAVITA INC.: NET SALES, (2021-2023)

FIGURE 30. DAVITA INC.: PRIMARY MARKET COMPETITORS

FIGURE 31. NIKKISO CO. LTD.: NET SALES, (2021-2023)

FIGURE 32. NIKKISO CO. LTD.: PRIMARY MARKET COMPETITORS

FIGURE 33. NXSTAGE MEDICAL, INC.: NET SALES, (2021-2023)

FIGURE 34. NXSTAGE MEDICAL, INC.: PRIMARY MARKET COMPETITORS

FIGURE 35. ASAHI KASEI CORPORATION: NET SALES, (2021-2023)

FIGURE 36. ASAHI KASEI CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 37. MEDICATORS, INC.: NET SALES, (2021-2023)

FIGURE 38. MEDICATORS, INC.: PRIMARY MARKET COMPETITORS

FIGURE 39. FRESENIUS MEDICAL CARE AG AND CO. KGAA: NET SALES, (2021-2023)

FIGURE 40. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRIMARY MARKET COMPETITORS

FIGURE 41. NIPRO CORPORATION: NET SALES, (2021-2023)

FIGURE 42. NIPRO CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 43. B. BRAUN AVITUM AG: NET SALES, (2021-2023)

FIGURE 44. B. BRAUN AVITUM AG: PRIMARY MARKET COMPETITORS

FIGURE 45. DIAVERUM DEUTSCHLAND GMBH: NET SALES, (2021-2023)

FIGURE 46. DIAVERUM DEUTSCHLAND GMBH: PRIMARY MARKET COMPETITORS

KEY PLAYERS

  • Baxter International, Inc.

  • DaVita Inc.

  • Nikkiso Co. Ltd.

  • NxStage Medical, Inc.

  • Asahi Kasei Corporation

  • Medicators, Inc.

  • Fresenius Medical Care AG & Co. KGaA

  • Nipro Corporation

  • B. Braun Avitum AG

  • Diaverum Deutschland GmbH


Frequently Asked Questions
Which are the top companies operating in the North America dialysis market?

The leading companies in North America dialysis market include Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., DaVita Inc., Nipro Corporation, B. Braun Melsungen AG, and others.

What is the estimated revenue of the North America dialysis market by the end of 2030?

According to projections from Next Move Strategy Consulting, the North America dialysis market is anticipated to reach USD 81.02 billion by 2030.

What are the key challenges faced by the North America dialysis market?

The significant challenges in the North America dialysis inherent risk of infections and complications associated with these procedures.

Which is the dominating region in the North America dialysis market?

The U.S. is the dominant region in the North America dialysis market.

What is the market size of the dialysis market in 2023?

The North America dialysis market was valued at USD 64.38 billion in 2023, as per the findings of Next Move Strategy Consulting's report.